Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhangyan Jing

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Frontiers in Immunology|November 21, 2022
Leverage biomaterials to modulate immunity for type 1 diabetesZhangyan Jing, Yuan Li, Yumeng Ma, et al.
Diabetes|May 21, 2024
Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 DiabetesZhaoxin Yang, Zhirang Zhang, Liyan Li, et al.
ACS Synthetic Biology|May 31, 2024
<i>In Situ</i> Synthesis of an Immune-Checkpoint Blocker from Engineered Bacteria Elicits a Potent Antitumor ResponseYuting Wei, Zhirang Zhang, Tianyuan Xue, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 13, 2026
CD4<sup>+</sup> Th Cell-Derived Extracellular Vesicles Orchestrate CD8<sup>+</sup> T Cells and Eosinophils to Enhance Anti-Tumor ImmunityZhaoxin Yang, Tianyu Lan, Rui Diao, et al.
Small Methods|January 6, 2023
Engineered Cell Membrane Vesicles Expressing CD40 Alleviate System Lupus Nephritis by Intervening B Cell ActivationTianliang Fang, Baoqi Li, Meng Li, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|November 21, 2022
Leverage biomaterials to modulate immunity for type 1 diabetesZhangyan Jing, Yuan Li, Yumeng Ma, et al.
Diabetes|May 21, 2024
Bioengineered Artificial Extracellular Vesicles Presenting PD-L1 and Gal-9 Ameliorate New-Onset Type 1 DiabetesZhaoxin Yang, Zhirang Zhang, Liyan Li, et al.
ACS Synthetic Biology|May 31, 2024
<i>In Situ</i> Synthesis of an Immune-Checkpoint Blocker from Engineered Bacteria Elicits a Potent Antitumor ResponseYuting Wei, Zhirang Zhang, Tianyuan Xue, et al.
Small (Weinheim an Der Bergstrasse, Germany)|May 13, 2026
CD4<sup>+</sup> Th Cell-Derived Extracellular Vesicles Orchestrate CD8<sup>+</sup> T Cells and Eosinophils to Enhance Anti-Tumor ImmunityZhaoxin Yang, Tianyu Lan, Rui Diao, et al.
Small Methods|January 6, 2023
Engineered Cell Membrane Vesicles Expressing CD40 Alleviate System Lupus Nephritis by Intervening B Cell ActivationTianliang Fang, Baoqi Li, Meng Li, et al.
Pageof 1